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Abstract 
The Tristetraprolin (TTP) protein family includes four mammalian members (TTP, TIS11b, 
TIS11d, and ZFP36L3), but only one in Drosophila melanogaster (DTIS11). These proteins bind 
target mRNAs with AU-rich elements (AREs) via two C3H zinc finger domains and destabilize 
the mRNAs. We found that overexpression of mouse TIS11b or DTIS11 in the Drosophila 
retina dramatically reduced eye size, similar to the phenotype of eyes absent (eya) mutants. 
The eya transcript is one of many ARE-containing mRNAs in Drosophila. We showed that 
TIS11b reduced levels of eya mRNA in vivo. In addition, overexpression of Eya rescued the 
TIS11b  overexpression  phenotype.  RNA  pull-down  and  luciferase  reporter  analyses 
demonstrated that the DTIS11 RNA-binding domain is required for DTIS11 to bind the eya 3 
UTR and reduce levels of eya mRNA. Moreover, ectopic expression of DTIS11 in Drosophila 
S2 cells decreased levels of eya mRNA and reduced cell viability. Consistent with these results, 
TTP proteins overexpressed in MCF7 human breast cancer cells were associated with eya 
homologue 2 (EYA2) mRNA, and caused a decrease in EYA2 mRNA stability and cell viability. 
Our results suggest that eya mRNA is a target of TTP proteins, and that downregulation of 
EYA by TTP may lead to reduced cell viability in Drosophila and human cells. 
Key words: eyes absent, tristetraprolin, Drosophila, AU-rich element, RNA stability. 
Introduction 
Gene expression in eukaryotic cells is a  highly 
dynamic  process,  involving  transcription,  splicing, 
mRNA export, mRNA localization, mRNA stabiliza-
tion,  and  translation.  In  mammals,  a  genome-wide 
study estimated that 40-50% of changes in gene ex-
pression in response to cellular signals occur at the 
level  of  mRNA  stability  [1].  The  AU-rich  elements 
(AREs) in mRNA 3 untranslated regions (UTRs) are 
recognized by a subset of RNA-binding proteins that 
modulate  RNA  stability  [2].  Tristetraprolin  (TTP) 
proteins bind AREs and destabilize mRNA [3]. This 
family is comprised of three proteins in man and four 
in  rodents  [4],  including  TTP  (also  called  TIS11, 
ZFP36, NUP475, or G0S24), TIS11b (ZFP36L1, ERF1, 
BRF1, or CMG1), TIS11d (ZFP36L2, ERF2, or BRF2), 
and the rodent-specific ZFP36L3 [5]. All TTP proteins 
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have  a  highly  conserved  C3H  tandem  zinc  finger 
(TZF) domain, which binds to AREs and promotes the 
deadenylation  and  destruction  of  ARE-containing 
target sequences [6,7]. 
In  macrophages,  TTP  affects  inflammation  by 
negatively  regulating  the  expression  of 
pro-inflammatory factors such as tumor necrosis fac-
tor  (TNF)  and  granulocyte-macrophage  colo-
ny-stimulating factor [8,9]. In Drosophila melanogaster, 
there is only one protein in the TTP family, DTIS11. 
Expression levels of antimicrobial peptides are regu-
lated  by  the  effects  of  DTIS11  on  mRNA  stability 
[10,11]. Biological function analyses have shown that 
overexpression  of  TTP  family  members  induces 
apoptosis in a variety of cell lines, including HeLa, 
U20S, SAOS1, 3T3, and B cell lymphoma cells [12–14]. 
Both TTP and TIS11b target cIAP2 mRNA to regulate 
apoptosis [15,16]. 
Using  systematic  genomic  approaches,  several 
mRNA targets of TTP proteins have been identified 
[17–19].  The Drosophila ARE database (D-ARED) in-
dicates  that  ~16%  of  Drosophila  genes  contain  the 
mammalian  ARE  signature,  an  AUUUA  pentamer 
within an AU-rich context [20]. In Drosophila, DTIS11 
temporally  regulates  gene  expression  through 
ARE-mediated  mRNA  decay  [20].  To  better  under-
stand  TTP  function  in  vivo,  we  overexpressed  TTP 
proteins in the fly retina. Strikingly, this resulted in a 
phenotype that was similar to eyes absent (eya) loss of 
function. We further demonstrated that eya mRNA is 
a TTP binding target, and that eya mRNA is down-
regulated in response to TTP in vivo. We performed 
similar analyses in MCF7 cells, a human breast cancer 
cell line, and found that TTP overexpression destabi-
lized EYA2 mRNA. These results suggest that the in-
teraction between TTP proteins and eya mRNA is a 
conserved regulatory mechanism that functions in a 
number of species and cell types. 
Materials and methods 
Plasmid constructs 
Drosophila  Gateway  technology  was  used  to 
generate  plasmids  for  expressing  tagged  proteins. 
Mouse  TIS11b  was  PCR  amplified  from  cDNA  de-
rived  from  mouse  RAW264.7  cells  (forward  primer 
5-CACCATGACCACCACCCTCGTGTC-3,  reverse 
primer  5-TTAGTCATCTGAGATGGAGAG-3). 
DTIS11 was PCR amplified from Drosophila EST clone 
LD36337  (NHRI,  Taiwan)  (forward  primer 
5-CACCATGTCTGCTGATATTCTGCAG-3,  reverse 
primer  5-TTAGAGTCCCAAATTGGACTG-3).  PCR 
fragments were cloned into pENTR/D-TOPO vector 
(Invitrogen),  confirmed  by  sequencing,  and  then 
transferred  into  Drosophila  Gateway  vectors  pTFW 
and pTGW (gifts from Dr. M.-T. Su) via the Clonase II 
reaction  (Invitrogen)  to  generate  FLAG-tagged  and 
GFP-tagged protein expression plasmids, respective-
ly. The 3 UTR of eya was PCR amplified from cDNA 
derived  from  fly  heads  (forward  primer 
5-GAAAGGCCAAACTGTAAGGG-3  [hereafter,  F 
primer],  reverse  primer  5-ATAGAGTGCGTT 
GCTGTTGG-3 [R primer]). The resulting PCR frag-
ment  was  ligated  into  pCRII-TOPO  vector  (Invitro-
gen),  sequenced,  and  transferred  into  the  3  end  of 
pCMV-FLAG-Luciferase  (Stratagene)  for  use  in  re-
porter assays. The 3 UTR was separated into three 
fragments  via  PCR  using  the  following  primers: 
fragment  1,  F  primer  and  5-CGGGTACCGATCG 
TTGATTAGGTGTTTA-3;  fragment  2,  5-GTAACA 
ATTCTCGCACGAAG-3  and  5-CAGCCAGGATG 
CGTATC-3;  fragment  3,  5-GAGAAGCGGA 
GCAAACAC-3 and R primer. These fragments were 
ligated  into  the  3  end  of  pCMV-FLAG-Luciferase. 
Coding sequences for mouse TIS11b and TIS11d were 
PCR amplified from cDNA derived from RAW264.7 
cells that had been treated for 2 h with lipopolysac-
charide.  For  TIS11b,  forward  and  reverse  primers 
were  5-  ATGACCACCACCCTCGTGTC-3  and 
5-TTAGTCATCTGAGATGGAGAG-3,  respectively. 
For  TIS11d,  forward  and  reverse  primers  were 
5-ATGTCGACCACACTTCTGTCAC-3  and 
5-TCAGTCGTCGGAGATGGAGAGGCG-3,  respec-
tively.  After  sequencing,  PCR  fragments  were  sub-
cloned into pCMV-Tag2B (Stratagene) and pEGFP-C2 
(Clontech)  for  expression  in  mammalian  cells.  The 
cloning of mouse TTP has been described [21].  
Site-directed mutagenesis 
DTIS11F158N and mTTPF118N mutants were gener-
ated using the QuikChange site-directed mutagenesis 
kit  (Stratagene).  For  these  reactions,  pTGW-DTIS11, 
pCMV-FLAG-DTIS11,  and  pCMV-FLAG-TTP  were 
used  as  templates.  Primers  containing  the  desired 
mutation  (underlined)  were  designed  as  follows: 
DTIS11,  forward  5-GAAGTGCCAGAACG 
CCCATGGA-3  and  reverse  5-TCCATGGGCG 
TTCTGGCACTTC-3;  TTP,  forward 
5-CAAGTGCCAGAATGCTCACGGC-3 and reverse 
5-GCCGTGAGCATTCTGGCACTTG-3.  All  muta-
tions were verified by sequencing.  
Fly stocks 
eya2, UAS-eya, UAS-GFP, tub-Gal80ts, and eq-Gal4 
flies were from Y. Henry Sun (Institution of Molecular 
Biology  [IMB],  Academia  Sinica,  Taiwan);  UAS-Bcl, 
UAS-p53DN,  UAS-p35,  UAS-DIAP,  UAS-mCD8GFP, Int. J. Biol. Sci. 2012, 8 
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Lz-Gal4,  and  GMR-Gal4 flies  were  from  the  Bloom-
ington  Stock  Center;  and  UAS-dTIS11RNAi  flies  were 
obtained from the Vienna Drosophila RNAi Center. All 
fly  stocks  were  maintained  in  23º  or  26ºC  environ-
mental  insect  culture  chambers.  The 
pUAS-FLAG-DTIS11,  pUAS-FLAG-mTIS11b, 
pUAS-GFP-mTIS11b,  pUAS-GFP-DTIS11,  and 
pUAS-FLAG-DTIS11F158N  expression  vectors  were 
introduced  into  flies  by  traditional  germ-line  trans-
formation at the IMB. 
Cell culture 
Drosophila  Schneider  (S2)  cells  were  grown  at 
25ºC  in  Schneider’s  Drosophila  medium  (Invitrogen) 
containing  10%  heat-inactivated  fetal  bovine  serum 
(FBS; Gibco-BRL). Human embryonic kidney (HEK) 
293T cells were grown at 37ºC and 5% CO2 in DMEM 
supplemented with 3.7 g/L sodium bicarbonate and 
10%  FBS.  Human  breast  cancer  cells  (MCF7)  were 
cultured  in  MEM  supplemented  with  2  mM 
L-glutamine, 0.1 mM non-essential amino acids, 1 mM 
sodium  pyruvate,  0.01  mg/mL  bovine  insulin,  and 
10%  FBS.  All  three  cell  lines  were  purchased  from 
Bioresource  Collection  and  Research  Center  (BCRC, 
Taiwan) 
Immunoblotting analysis 
 Fly heads or cultured cells were harvested and 
extracted in whole-cell extract buffer (25 mM HEPES, 
pH 7.5, 300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 
0.1%  (v/v)  Triton  X-100,  0.5  mM  DTT).  Whole-cell 
extracts  (20  g)  were  separated  by  SDS-PAGE  and 
detected using anti-FLAG (Sigma-Aldrich), anti-GFP 
(GeneTex), anti-Eya (Drosophila Hybridoma Bank), or 
anti--H2AX (Cell Signaling). The peroxidase labeled 
goat  anti-rabbit  or  goat  anti-mouse  secondary  anti-
body (KPL) in combination with Western Lightning- 
enhanced chemiluminescence substrate (PerkinElmer) 
were used for detection on X-ray film from FUJIFILM 
Corporation.  
RNA immunoprecipitation (RNA-IP) 
Whole-cell  extracts  (300  g)  from  control  fly 
heads or fly  heads expressing FLAG-mTIS11b were 
adjusted to 25 mM HEPES, pH 7.5, 150 mM NaCl, 1.5 
mM MgCl2, 0.2 mM EDTA, 0.1% (v/v) Triton X-100, 
0.5  mM  DTT,  and  1  U/L  RNasin.  Samples  were 
pre-cleaned  with  protein  ASepharose  (Amersham 
Pharmacia)  for  1  h.  After  centrifugation,  an-
ti-FLAG-Sepharose (Sigma-Aldrich) was added to the 
supernatants and rotated at 4ºC for 2 h. Beads were 
washed  three  times  using  NT2  buffer  (50  mM 
Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM MgCl2, 0.05% 
NP-40) and then incubated with 100 L NT2 buffer 
containing 5 U RNase-free DNase I (Ambion) for 15 
min at 30ºC. Beads were washed once with NT2 buffer 
and then incubated in 100 L NT2 buffer containing 
0.1% SDS and 0.5 mg/mL proteinase K at 55ºC for 15 
min.  For  RT-PCR,  RNA  was  extracted  with  TRIzol 
(Invitrogen). cDNAs of interest were amplified using 
4% of the RT reaction in a 20-µL PCR reaction con-
taining 10 pmol forward and reverse primers, respec-
tively:  eya,  5-CCTGGCTACAGATACGCTCG-3  and 
5-TGGAGGTTACCAGCACGTTG-3;  rp49,  5-GCG 
CACCAAGCACTTCATC-3  and  5-GTAAACGC 
GGTTCTGCATGAG-3. PCR products were separat-
ed  using  2%  agarose  gel  electrophoresis. 
FLAG-tagged  TTP  and  TTPF118N  were  expressed  in 
MCF7 cells, and whole-cell extracts were isolated to 
perform  RNA-IP.  After  RNA  isolation  and  reverse 
transcription, human EYA2 and -actin mRNA were 
detected by PCR using the following primers: EYA2, 
5-GGACAATGAGATTGAGCGTGT-3  and  5-ATGT 
GGGGTTGAGTAAGGAGT-3;  -actin,  5-GCAC 
CAGGGCGTGATGG-3  and  5-GCCTCGGTCAGCA 
GCA-3.  
RNA pull-down analysis 
To overexpress mouse TTP family proteins and 
DTIS11, 1 × 107 HEK293T cells were transfected with 
GFP-TTP,  GFP-TIS11b,  GFP-TIS11d,  GFP-DTIS11, 
FLAG-DTIS11,  or  FLAG-DTIS11F158N  expression 
plasmid (10 μg) using calcium phosphate precipita-
tion.  Cytoplasmic  extracts  were  prepared  using  hy-
potonic buffer (10 mM HEPES, pH 7.5, 10 mM potas-
sium acetate, 1.5 mM MgCl2, 2.5 mM dithiothreitol, 
0.05%  NP-40,  protease  inhibitor  cocktail  (Sig-
ma-Aldrich),  and  phosphatase  inhibitors  containing 
0.01 M -glycerol phosphate, 0.1 mM Na2MoO4, 0.1 
mM Na3VO4, pH 10.0, and 0.01 M NaF). The potas-
sium  acetate  concentration  of  the  extracts  was  ad-
justed to 90 mM, and then 0.2 U/µL RNase inhibitor 
(Promega) and 0.1 µg/µL yeast tRNA (Ambion) were 
added.  Extracts  were  incubated  with  15  L  hepa-
rin-agarose  (Sigma-Aldrich)  at  4ºC  for  15 min,  and 
subsequently  cleaned  with  10  L  streptavi-
din-Sepharose (Invitrogen) for 1 h at 4ºC with rota-
tion. In vitrotranscribed biotinylated ARE (4 µg) from 
the  3  UTR  of  eya,  TTP,  TNF, or  control  18S rRNA 
(T7-MEGAshortscript,  Ambion)  was  added  to  the 
supernatant, and the mixture was incubated for 1 h at 
4ºC.  The  protein  and  biotinylated  RNA  complexes 
were  recovered  by  addition  of  10  L  streptavi-
din-Sepharose  at  4ºC  for  2  h  with  rotation.  After 
washing  four  times  with  binding  buffer  (10  mM 
HEPES,  pH  7.5,  90  mM  potassium  acetate,  1.5  mM 
MgCl2, 2.5 mM dithiothreitol, 0.05% NP-40, and pro-Int. J. Biol. Sci. 2012, 8 
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tease  and  phosphatase  inhibitor  cocktails), 
pulled-down  complexes  were  analyzed  by  im-
munoblotting using anti-FLAG. 
Transfection and luciferase reporter analysis 
HEK293T cells were seeded into six-well plates 
at a density of 2 × 105 cells/well. The next day, cells 
were transfected using calcium phosphate precipita-
tion  (0.5  µg  pCMV-FLAG-luciferase  or 
pCMV-FLAG-luciferase-eya 3 UTR constructs, 0.01 µg 
pCMV--galactosidase,  and  indicated  dosages  of 
DTIS11 and DTIS11F158N expression vectors). After 36 
h,  RNA  was  isolated  for  quantitative  PCR  analysis 
(described in next section), and cell lysates were col-
lected  for  luciferase  and  -galactosidase  activity  as-
says [22] and  immunoblotting. To correct for varia-
tions  in  the  transfection  efficiency  and  expression 
level of each construct, luciferase assay values were 
divided  by  the  -galactosidase  value  and  then  nor-
malized to the control group. Each treatment condi-
tion was performed in duplicate, and each experiment 
was repeated three times independently. 
RNA isolation and quantitative PCR 
To examine endogenous eya mRNA expression, 
S2 cells were seeded into six-well plates at a density of 
5  ×  105  cells/well  and  transfected  with  3  μg  of 
pAC5.1-GFP,  pAC5.1-GFP-DTIS11,  or 
pAC5.1-GFP-DTIS11F158N  using  Lipofectamine  2000 
(Invitrogen). After 24 h, total RNA was collected us-
ing  TRIzol.  Total  RNA  (20  µg)  was  subsequently 
treated with TURBO DNase (Ambion) at 37ºC for 1 h, 
and  then  extracted  using  TRIzol.  Total  RNA  (5  µg) 
was reverse-transcribed to cDNA in the presence of 
0.5  μg  oligo-dT  primer  using  M-MLV  reverse  tran-
scriptase (Promega). Quantitative real-time PCR was 
performed in a total volume of 20 µL with FastStart 
Universal  PCR  Master  Mix  (Roche)  on  an  Applied 
Biosystems  7300  Real-Time  PCR  System.  Reactions 
contained cDNA template plus forward and reverse 
primers  for  eya  and rp49 (0.4  µM  each).  Similar  ex-
periments  were  performed  in  MCF7  cells  overex-
pressing TTP family proteins. In these experiments, 
PCR was carried out using human EYA2 and -actin 
primers. RNA from HEK293T cells (described above) 
was  analyzed  by  PCR  using  luciferase  primers 
(5-ACAACACCCCAACATCTTCGA-3  and 
5-CGTCTTTCCGTGCTCCAAAA-3)  and 
-galactosidase  primers  (5-GGATGTCGCTCCA 
CAAGGTAA-3  and  5-CGGTTGCACTACG 
CGTACTGT-3).  Amplification  conditions  were  40 
cycles of 95ºC for 15 s and 60ºC for 1 min. Results were 
analyzed using a mathematical Ct method.  
MTS cell viability assay  
S2 cells or MCF7 cells were seeded into 96-well 
plates at a density of 1 × 104 cells/well with 100 μL 
culture medium. They were transfected with 0.2 μg 
DNA using Lipofectamine 2000. After 2 days, 20 μL 
CellTiter  96  AQueous  One  Solution  (Promega)  was 
added to each well, and cells were incubated at 25º (S2 
cells) or 37 ºC (MCF7 cells) for 2 h. Absorbance at 490 
nm was recorded using a SpectraMax M2e Microplate 
Reader (Molecular Devices). Each treatment condition 
was performed in triplicate, and each experiment was 
repeated at least three times independently. 
Determination of cell number in MCF7 cells 
MCF7 cells were seeded into six-well plates at a 
density of 1  105 cells/well and transfected with ex-
pression vectors for GFP-tagged TTP family proteins 
using Lipofectamine 2000. The medium was changed 
after 20 h transfection and cells were harvested after 
further 20 h. Cells were stained with trypan blue and 
counted in a Countess Automated Cell Counter (Invi-
trogen) following the manufacturer’s instructions. 
Statistical analysis 
Luciferase  reporter  activity  and  RNA,  endoge-
nous eya mRNA, and MTS cell survival assays were 
quantified using one-tailed Student’s t-test. Drosophila 
eye size was analyzed using  ImageJ and two-tailed 
Student’s t-test. 
 
Results 
Overexpression of TIS11 proteins result in a 
small eye phenotype  
To investigate the biological function of TTP, we 
used  the  Drosophila  genetic  system  to  express  both 
mouse and fly TIS11. Fig. 1A shows the amino acid 
sequences  of  DTIS11  and  three  mouse  TTP  family 
members.  The  proteins  have  highly  conserved  TZF 
domains, but variable N- and C-terminal sequences. 
GFP-tagged  TTP,  TIS11b,  TIS11d,  and  DTIS11  were 
expressed in HEK293T cells and shown to bind the 
ARE from TNF using a pull-down assay (Fig. 1B). This 
indicates that DTIS11 and mouse TTP proteins have 
similar  RNA-binding  activity.  Moreover,  DTIS11  or 
mouse TIS11b expressed in the fly retina by specific 
GMR-Gal4 caused an eyes absent or small eye phe-
notype, respectively (Figs. 2A–C). When DTIS11 was 
expressed in the fly retina by a pigment cell driver, 
Lz-Gal4,  the  number  of  pigment  cells  was  dramati-
cally  reduced  and  rhabdomere  structure  was  dis-
rupted (Fig. 2E).  Int. J. Biol. Sci. 2012, 8 
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Figure 1. Comparison between Drosophila and mouse TTP family members. (A) Amino acid sequences of Drosophila DTIS11 
and mouse TTP family members. (B) HEK293T cells were transiently transfected with GFP vector or GFP-tagged TTP, TIS11b, TIS11d, or 
DTIS11 expression vectors. After 24 h, cytosolic extracts were isolated and incubated with biotinylated TNF ARE or control 18S rRNA. 
The pulled down proteins were subjected to immunoblot analysis using anti-GFP. 
 Int. J. Biol. Sci. 2012, 8 
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Figure 2. Overexpression of DTIS11 proteins in the Drosophila eye. (A-D) Bright field images of fly retinas expressing TIS11 
variants  by  GMR-Gal4.  (A,  control;  B,  Drosophila  TIS11  [DTIS11];  C,  murine  TIS11b  [mTIS11b];  D,  RNA-binding  domain  mutant 
DTIS11F158N). (E) Use of the pigment cell driver Lz-Gal4 to express DTIS11 in retina. Pupal eyes (48 h APF) were dissected and labeled by 
immunohistochemistry (left, control; right, DTIS11 overexpression). Retinal pigment cells were revealed by anti-armadillo staining 
(green), and rhabdomere structure of photoreceptors was counterstained with phalloidin (red). Scale bar, 10 m. (F) Immunoblot analysis 
of total protein from fly heads for expression of DTIS11 and DTIS11F158N. w1118 was used as a non-transgenic control. Numbers below 
bands indicate amount of protein loaded. 
 
The number of interommatidial cells is known to 
be  precisely  regulated  by  programmed  cell  death 
[23,24]. The severe reduction in the number of inter-
ommatidial  cells  in  this  experiment  implied  that 
overexpression of DTIS11 induced apoptosis. To nar-
row down this apoptotic time window and to deter-
mine which developmental stage was most affected 
by DTIS11, we used a temperature-sensitive Gal4 re-
pressor  (Gal80ts) [25]  to temporally regulate DTIS11 
expression in the eye. When DTIS11 overexpression 
was  initiated  during  pupal  development,  the  eye 
phenotype was much milder than with the conven-
tional  GMR-Gal4,  which  drives  constitutive  expres-
sion from embryonic stages (Supplementary Material: 
Fig. S1). Notably, when DTIS11 overexpression com-
menced at a late pupal stage (~85% after puparium 
formation  [APF]),  numerous  black  spots—typically 
indicative  of  apoptosis—were  present  in  the  adult 
retina.  Consistent  with  this  observation,  the 
DTIS11-induced  small  eye  phenotype  was  partially 
rescued by two apoptosis inhibitors, Drosophila inhib-
itor  of  apoptosis  (DIAP)  and  p35  (Supplementary 
Material: Fig. S2).  
Due  to  TTP  family  members  belonging  to 
RNA-binding  proteins,  we  next  tested  whether  the 
mRNA-binding capability of DTIS11 was required to 
cause eye deficits. To this end, we generated a trans-
genic  fly,  UAS-DTIS11F158N,  expressing  a  protein  in 
which the TZF RNA-binding domain, which is critical 
for TTP function [26], was mutated. Interestingly, eyes 
expressing DTIS11F158N did not exhibit an eyes absent 
phenotype and were morphologically indistinguisha-
ble  from  wild  type  (Fig.  2D).  Immunoblot  analysis 
confirmed  that  DTIS11F158N  was  indeed  expressed 
(Fig. 2F). Although DTIS11F158N was more abundantly 
expressed than wild-type DTIS11, it did not elicit an Int. J. Biol. Sci. 2012, 8 
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aberrant  eye  appearance  without  a  functional 
RNA-binding  domain.  Taken  together,  our  results 
show that overexpression of DTIS11 in the fly retina 
leads to eye defects, and that the RNA-binding activ-
ity of DTIS11 is required for this phenotype. 
eya mRNA is a target of TTP proteins 
To determine the mechanism by which DTIS11 
affects eye development, we attempted to identify its 
mRNA  binding  targets  by  performing  RNA-IP.  We 
took  a  candidate  gene  approach,  concentrating  on 
ARE-containing  genes  that  play  a  role  in  apoptosis 
based on a search of D-ARED data [20]. However, the 
level  of  DTIS11  protein  in  the  eye  was  too  low  for 
RNA-IP  (Fig.  2F),  likely  because  of  the  reduced 
amount of eye tissue. Thus, RNA-IP was performed 
using eyes expressing FLAG-tagged mTIS11b, which 
elicited a milder phenotype (Fig. 2C). Using FLAG-IP, 
RNA was isolated for reverse transcription followed 
by  semi-quantitative  PCR  analysis  (Supplementary 
Material: Fig. S3). The candidate gene eya exhibited a 
reduction in mRNA and protein level in response to 
mTIS11b  expression  (Fig.  3A).  Furthermore,  eya 
mRNA and mTIS11b were present in the same com-
plex (Fig. 3A). To confirm that endogenous Eya was 
downregulated spatially in the fly retina by overex-
pression  of  TIS11  proteins,  we  performed  Eya  anti-
body  staining  in  eye  imaginal  discs.  As  previously 
reported [27,28], we found endogenous Eya expressed 
primarily  behind  the  morphogenetic  furrow  (Sup-
plementary Material:  Fig.  S4), where the  GMR-Gal4 
was  specifically  expressed.  Subsequently,  when  we 
knocked down  DTIS11 by  eq-GAL4-driven RNAi, it 
resulted  in  Eya  accumulation  and  expansion  in  the 
area  before  the  morphogenetic  furrow  (Supplemen-
tary Material: Fig. S5). Interestingly, the eya null phe-
notype  is  quite  similar  to  that  seen  with  DTIS11 
overexpression [27] (Fig. 3B). In addition, eya overex-
pression  was  able  to  partially  rescue  the  small  eye 
phenotype caused by TIS11b (Figs. 3C and D). To rule 
out  the  possibility  of  unexpected  effects  on  cell 
growth  from  GMR-Gal4  driving  UAS-Eya,  Eya  was 
overexpressed alone in the fly retina. It did not result 
in an overgrown eye phenotype (Supplementary Ma-
terial: Fig. S6), clarifying that Eya overexpression in-
deed could rescue TIS11b mediated small eye pheno-
type. These results suggest that eya mRNA is a target 
of TIS11 proteins in vivo, and that downregulation of 
eya  mRNA  by  DTIS11  or  mTIS11b  overexpression 
may result in the small eye phenotype. 
Physical and functional interactions between 
DTIS11 and the 3 UTR of eya 
To characterize the interaction between eya and 
DTIS11, the ARE-containing 3 UTR of eya mRNA was 
evaluated. The 3 UTR was isolated and separated into 
three fragments for binding analyses (Fig. 4A). RNA 
pull-down experiments indicated that DTIS11 bound 
to the full-length eya 3 UTR and to fragment 1 (the 
most proximal fragment to the coding sequence), but 
not to fragment 2 or 3 (Fig. 4B). As a positive control, 
we used the TTP ARE, a well-characterized ARE in 
the 3 UTR of mouse TTP mRNA [22]. In addition, the 
DTIS11F158N  mutant  did  not  bind  the  3  UTR  of  eya 
(Fig. 4B).  
To  carry  out  reporter  assays,  we  cloned  the 
full-length 3 UTR and each fragment into the 3 end of 
the luciferase gene. HEK293T cells were cotransfected 
with the luciferase-eya 3 UTR reporter plasmid plus a 
FLAG-tagged DTIS11 expression plasmid, and lucif-
erase activity was measured 24 h  after transfection. 
DTIS11 protein levels are shown in the lower panel of 
Fig. 4C. Consistent with our RNA-protein interaction 
data, DTIS11 significantly reduced luciferase activity 
when the full-length 3 UTR or fragment 1 was tested. 
Similar results were seen with TTP ARE. Downregu-
lation  of  luciferase  activity  by  DTIS11  was  also  re-
flected in decreased levels of luciferase mRNA (Fig. 
4D). In contrast, DTIS11F158N did not affect luciferase 
activity  or  RNA  expression  (Figs.  4C  and  D).  Alt-
hough fragment 2 did not pull down DTIS11 protein 
(Fig. 4B), luciferase activity was attenuated by DTIS11 
overexpression  using this  fragment (Fig. 4C).  These 
results demonstrate that DTIS11 binds to the 3 UTR of 
eya mRNA (specifically, fragment 1), thereby reducing 
eya expression. 
DTIS11 downregulates eya expression and af-
fects viability of S2 cells 
To  further  demonstrate  the  downregulation  of 
eya  mRNA  expression  by  DTIS11,  we  transfected 
DTIS11 and DTIS11F158N into Drosophila embryonic S2 
cells.  Total  RNA  was  isolated  and  eya  mRNA  was 
detected by quantitative PCR. Compared to the empty 
vector  and  the  RNA-binding  mutant  DTIS11F158N  as 
negative controls, DTIS11 overexpression significant-
ly  decreased  eya  mRNA  levels  (Fig.  5A,  left  panel). 
Immunoblotting revealed the levels of overexpressed 
GFP-tagged proteins (Fig. 5A, right panel). Moreover, 
data from MTS cell viability assays revealed that the 
viability of cells overexpressing DTIS11 was signifi-
cantly reduced compared with vector or DTIS11F158N 
controls  (Fig.  5B).  Given  the  low  transfection  effi-
ciency  of  S2  cells  with  Lipofectamine  (<40%),  dra-
matic decreases of eya expression and cell viability is 
unlikely. This indicates that DTIS11 may impair cell 
viability by destabilizing eya mRNA in S2 cells. Int. J. Biol. Sci. 2012, 8 
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Figure  3.  Identification  of  eya  mRNA  as  a  target  of  TIS11  proteins  in  Drosophila.  (A)  Analysis  of  eya  expression. 
Semi-quantitative RT-PCR determines the mRNA expression of eya (top) and rp49 (middle), and the level of eya mRNA bound to 
FLAG-tagged TIS11b (bottom) in control and mouse TIS11b overexpression fly. Numbers indicate amount of RNA-IP reaction analyzed 
by quantitative PCR. Right panel is immunoblotting analysis with anti-Eya. (B) Eye phenotype resulting from DTIS11 overexpression was 
similar to the eya mutant. (C) Coexpression of eya with mTIS11b partially rescued the small eye phenotype caused by overexpression of 
mTIS11b alone. (D) Statistical analysis shows that eya significantly rescued the reduced eye size resulting from mTIS11b overexpression. 
n = 3; *P = 0.0048 by two-tailed Student's t-test. Int. J. Biol. Sci. 2012, 8 
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Figure 4. Physical and functional interactions between DTIS11 and 3 UTR of eya mRNA. (A) Nucleotide sequence of the 3 
UTR of Drosophila eya (GenBank accession no. NM_164693, nt 2511–3073) separated into three fragments (fragment 1, nt 2511–2730; 
fragment 2, nt 2731–2860; fragment 3, nt 2861–3073). AREs are indicated by bold text. (B) RNA pull-down assay using full-length (FL) eya 
3’UTR and eya 3’UTR fragments (#1, #2, and #3) with FLAG-tagged DTIS11 (WT) and DTIS11F158N (F158N). TTP ARE and 18S rRNA 
were used as positive and negative controls, respectively. The pulled down proteins were immunoblotted with anti-FLAG. (C-D) The 
luciferase gene was fused to full-length eya 3 UTR or 3 UTR fragments, and HEK293T cells were cotransfected with a luciferase plasmid 
and FLAG-DTIS11 or FLAG-DTIS11F158N expression plasmids. A TTP AREcontaining luciferase plasmid served as a positive control. After 
24 h, cell lysates were isolated for luciferase activity assays. Relative eya 3 UTRmediated luciferase activity is presented as mean ± SD. 
*P < 0.05, **P < 0.01, ***P < 0.001. The expression level of wild-type or mutant DTIS11 was determined by immunoblotting with an-
ti-FLAG (the arrows indicate FLAG-luciferase signal) (C). (D) Quantitative PCR was used to determine full-length eya 3’UTR-mediated 
luciferase mRNA expression. Expression data were normalized to -galactosidase mRNA and are shown as mean ± SD. *P < 0.05. Du-
plicate reactions were performed and each experiment was repeated three times. Int. J. Biol. Sci. 2012, 8 
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Figure 5. Overexpression of DTIS11 in S2 cells. (A) Overexpression of DTIS11 decreased eya mRNA expression in S2 cells. S2 cells 
were transfected with GFP-tagged DTIS11 (WT) or GFP-tagged DTIS11F158N (F158N) expression plasmids. eya expression was deter-
mined by quantitative PCR and normalized to rp49 as a negative control (*P < 0.05, **P < 0.01). Levels of GFP-tagged proteins were 
detected by immunoblotting with anti-GFP. (B) Cell viability analysis. S2 cells were seeded into 96-well plates and transiently transfected 
with GFP-tagged DTIS11 or DTIS11F158N expression plasmids. After 2 days, cell viability was determined by MTS assay and normalized to 
vector control (**P < 0.01, ***P < 0.001). Each treatment was performed in triplicate and the experiment was repeated five times.  
 
 
Overexpression of TTP proteins downregu-
lates EYA2 mRNA levels in human breast 
cancer cells 
We next asked whether the interactions between 
eya  mRNA  and  DTIS11  were  evolutionarily  con-
served.  In  the  human  genome,  there  are  four  eya 
homologs (EYA1–4), and each mRNA contains a long 
3  UTR  (1905,  709,  4096,  and  3314  bp,  respectively) 
with  putative  AREs  based  on  sequence  analysis. 
Human  EYA2  is  upregulated  in  the  human  breast 
cancer cell line MCF7 [29,30]. We transiently overex-
pressed individual mouse TTP proteins in MCF7 cells 
and  measured  EYA2  expression  and  cell  viability. 
TTP, TIS11b, and TIS11d decreased EYA2 mRNA lev-
els, while the TTPF118N mutant did not (Fig. 6A, top). 
Trypan blue staining showed that overexpression of 
wild-type  TTP  proteins  caused  a  decrease  in  the 
number of live cells (Fig. 6A, middle). MTS cell via-
bility analysis was shown in Supplementary Material: 
Fig.  S7A.  To  determine  whether  TTP  could  induce 
apoptosis in MCF7 cells, we performed immunoblot-
ting for -H2AX (Ser139-phosphorylated histone pro-
tein  H2AX),  which  is  induced  by  loss  of  EYA  and 
some  apoptotic  signals  [31–33].  Compared  to  the 
vector and mutant TTP, overexpression of wild-type 
TTP  increased  the  -H2AX  signal  (Supplementary 
Material:  Fig.  S7B).  Furthermore,  TUNEL  assays 
showed  that  wild-type  TTP  increased  the  apoptotic 
response (Supplementary Material: Fig. S7C). To de-
termine  whether  TTP  downregulates  EYA2  mRNA 
levels by accelerating its decay, we measured EYA2 
mRNA  stability  using  actinomycin  D  treatment  to 
block  RNA  synthesis  (Fig. 6B).  These  data  revealed Int. J. Biol. Sci. 2012, 8 
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that  EYA2  mRNA  decayed  more  rapidly  in  MCF7 
cells expressing TTP than in  MCF7 cells expressing 
GFP or TTPF118N. RNA-IP demonstrated that TTP, but 
not TTPF118N, was associated with EYA2 mRNA (Fig. 
6C). Collectively, these results demonstrate that TTP 
bound  to  and  destabilized  EYA2  mRNA,  and  that 
overexpression of TTP proteins decreased viability in 
MCF7 cells. 
 
 
Figure 6. Overexpression of TTP proteins in MCF7 cells. (A) TTP proteins downregulated human EYA2 (hEYA2) expression and 
cell viability in MCF7 cells. MCF7 cells were transiently transfected with GFP vector or GFP-tagged TTP, TIS11b, TIS11d, or TTPF118N 
expression vectors. After 40 h, EYA2 expression was measured by quantitative PCR (top), cell viability was measured using trypan blue 
(middle), and immunoblotting was performed using anti-GFP (bottom). *P < 0.05, **P < 0.01, ***P < 0.001. (B) Determination of EYA2 
mRNA stability. MCF7 cells were transiently transfected with GFP-TTP or GFP-TTPF118N expression vectors. A vector-only control was 
also included. After 40 h, cells were untreated or treated with 10 g/ml actinomycin D (Act D) for 15 and 30 min. RNA was then isolated 
for  quantitative  PCR  using  EYA2  and  -actin  primers.  (C)  RNA-IP.  MCF7  cells  were  transiently  transfected  with  FLAG-TTP  or 
FLAG-TTPF118N expression vector. A vector-only control was also included. After 24 h, cell lysates were isolated for immunoprecipitation 
using anti-FLAG M2 beads. RNA was extracted from the precipitated complexes for RT-PCR analysis using EYA2 and -actin primers. 
 
Discussion 
In this study,  we overexpressed DTIS11 in  the 
Drosophila retina, resulting in a small eye phenotype 
due to programmed cell death. In contrast, a mutant 
DTIS11 in which the RNA-binding TZF domain had 
been mutated had virtually no effect on the eye. This 
suggests  that  RNA-binding  activity  is  critical  for 
DTIS11 function. Using RNA-IP, we identified a novel 
TIS11  target  mRNA,  eya.  We  demonstrated  that 
DTIS11 physically interacted with the 3 UTR of eya 
mRNA  to  reduce  mRNA  expression.  Furthermore, 
decreased expression of  eya was correlated with re-
duced cell viability in Drosophila S2 and human MCF7 Int. J. Biol. Sci. 2012, 8 
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cells. Together, these data indicate that eya mRNA is 
depleted when TIS11 levels are elevated. In addition, 
this  interaction  represents  a  regulatory  mechanism 
that has been conserved during evolution. 
The eya gene was first identified in  Drosophila, 
where it functions to determine retinal cell fate [27]. 
eya mutations lead to an elevated rate of apoptosis in 
ommatidial precursor cells, preventing development 
of the compound eye [34,35]. In vertebrates, four eya 
homologs  have  been  identified,  each  containing  an 
N-terminal  transactivation  domain  and  threonine 
phosphatase  domain,  and  a  C-terminal  tyrosine 
phosphatase  domain  [36].  These  proteins  activate 
c-myc gene expression for cell proliferation [37], and 
regulate DNA repair via dephosphorylation of H2AX 
[31]. TTP mRNA and protein levels are significantly 
decreased  in  tumors  of  the  thyroid,  lung,  ovary, 
uterus, and breast compared to non-transformed tis-
sues [38,39]. Restoring TTP expression in an aggres-
sive tumor cell line suppresses cell proliferation and 
stimulates apoptosis [40]. In contrast, EYA levels are 
upregulated in a number of cancers, including EYA2 
in ovarian and breast cancers [29], EYA1 in Wilms’ 
tumor [41], and EYA4 in malignant peripheral nerve 
sheath  tumors  [42].  Moreover,  overexpression  of 
EYA1, EYA2, or EYA3 increases proliferation, inva-
sion, and transformation of breast cancer cells [43]. It 
appears, therefore, that TTPs and EYAs have inverse 
patterns of expression and functional effects in tumor 
cells. This is consistent with our observation that TTP 
overexpression reduced EYA2 mRNA levels and cell 
viability. As such, TTP proteins may target eya mRNA 
to regulate cell survival. However, eya overexpression 
only partially rescues the small eye phenotype caused 
by  mTIS11b.  We  also  failed  to  rescue  the 
DTIS11overexpression-induced  eyes  absent  pheno-
type by coexpression of eya (data not shown). These 
suggest  that  other  apoptosis-related  genes,  such  as 
diap1 and a gene encoding the eye-specific transcrip-
tion factor glass [44] (Supplementary Material: Fig. S3), 
or  other  unidentified  ARE-containing  mRNAs  may 
also be targets of TIS11 proteins and contribute to the 
phenotypic outcome. 
The  3  UTR  of  Drosophila  eya  mRNA  contains 
multiple  AREs.  To  functionally  characterize  the  3 
UTR, we separated it into three fragments. Fragment 1 
contains  four  AREs,  and  the  other  two  contain  one 
each. Fragment 1 bound most effectively to DTIS11. 
Although fragment 2 did not pull down TTP in bio-
chemical  experiments,  it  responded  to  DTIS11  ex-
pression in vivo. A similar effect was observed when 
TTP regulation of VEGF mRNA was examined [45]. In 
addition, several potential mRNA targets of TTP that 
were identified in a previous microarray experiment 
do not contain typical AREs [17,18]. This suggests that 
TTP  may  regulate  the  stability  of  these  mRNAs 
through  a  binding-independent  mechanism.  To  de-
termine whether TTP regulates eya mRNA stability in 
mammalian cells, we analyzed the mRNA sequences 
of four eya homologs. Each had a long 3 UTR con-
taining putative AREs and U-rich sequences. EYA2 is 
the predominant EYA family member in MCF7 cells 
[30]. RNA-IP analysis demonstrated that TTP associ-
ated with EYA2 mRNA and destabilized it. This im-
plies  that  overexpression  of  EYA2  in  breast  cancer 
MCF7 cells can be post-transcriptionally downregu-
lated  by  TTP  proteins.  The  detailed  physical  and 
functional interactions between TTP family members 
and  human EYA  mRNAs  should be further charac-
terized. 
 When the amino acid sequence of DTIS11 was 
compared with the mouse homologs TTP, TIS11b, and 
TIS11d,  DTIS11  was  most  similar  to  TIS11b  and 
TIS11d (Fig. 1A). These proteins share 90% amino acid 
identity within the TZF domain, but  have quite di-
vergent  N- and C-terminal sequences.  The TZF do-
main is responsible for RNA binding, whereas the N- 
and C-terminal regions recruit the mRNA decay ma-
chinery (e.g., deadenylase  [46–48], 5 mRNA decap-
ping [49], and 3 exosome [50] complexes). In our ex-
periments,  DTIS11  was  able  to  downregulate 
ARE-mediated  luciferase  activity  in  HEK293T  cells, 
indicating that interactions between TTP proteins and 
proteins  involved  in  mRNA  decay  may  have  been 
evolutionarily conserved. Although overexpression of 
either TIS11b or DTIS11 disrupted Drosophila eye de-
velopment,  the  effects  seen  with  TIS11b  were  less 
dramatic. Thus, there may be slight differences in the 
way these two proteins interact with effector proteins. 
For  example,  the  Cbl-interacting  protein  CIN85  in-
teracts  with  the  C  terminus  of  human  TTP  but  not 
with other protein family  members [51]. It has also 
been reported that TTP, but not TIS11b, interacts with 
the Tax protein from human T lymphotropic virus 1 
through its C-terminal domain [52]. 
Studies in animal model systems have demon-
strated that TTP plays a critical role in the immune 
system,  whereas  TIS11b  and  TIS11d  may  function 
during  embryonic  development  [53–55].  Although 
DTIS11 is most similar to TIS11b and TIS11d at the 
amino  acid  level,  it  is  functionally  most  similar  to 
TTP. For example, DTIS11 regulates the mRNA sta-
bility of anti-microbial peptides [10,11]. Here, we have 
identified a novel mRNA target of DTIS11, eya, and 
provided in vivo evidence that DTIS11 regulates eye 
development by interacting with and destabilizing eya 
mRNA, especially during embryogenesis. These ob-
servations also suggest that this single gene in Dro-Int. J. Biol. Sci. 2012, 8 
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sophila may be responsible for functions that are car-
ried out by multiple genes in mice and humans. 
Supplementary Material 
Fig.S1–S7. http://www.biolsci.org/v08p0606s1.pdf 
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